Company Research Report: Stockert GmbH

1. Company Overview

• Name: Stockert GmbH

• Mission: Develop and manufacture innovative, safe, and user-friendly solutions for minimally invasive therapies to improve the quality of life for patients and their families.

• Founded: 1985 by Rüdiger Stockert.

• Key People: Christoph Gerber, CEO; Klaus Welte, CEO (noted in a past interview).

• Headquarters: Bötzinger Straße 31, 79111 Freiburg, Baden-Württemberg, Germany.

• Number of Employees: Approximately 51-200 employees.

• Revenue: No information is available.

• Known For: High-tech medical equipment, especially in the fields of high-frequency ablation and nerve stimulation. Stockert's products are known for their reliability and intuitive operation, playing a crucial role in cardiac electrophysiology and regional anesthesia.

2. Products

2.1 Cardiological Electrophysiology

• HF Ablation System: A high-frequency ablation technology designed for the treatment of cardiac arrhythmias.

• Key Product: G4 High-frequency Generator.

• Key Features:

• Minimal-invasive treatment.

• Reduces procedure time, allowing quick recovery.

• Designed for precision in targeting treatment areas.

2.2 Regional Anesthesia and Pain Therapy

• Nerve Stimulator: Stimuplex® HNS12.

• Key Features:

• Provides precise localization of the target nerve through peripheral nerve stimulation.

• Streamlines the procedure by combining nerve stimulation and subsequent anaesthesia.

3. Recent Developments

• Recent Developments: Stockert continues to innovate within the medical device sector by developing advanced solutions and expanding its product range.

• New Products Launched: No specific new product launches mentioned.

• New Features Added: No information is available regarding new features added to existing products.

• New Partnerships: Stockert has a history of collaboration with major medical technology companies worldwide (specific partnerships not detailed).

4. Historical Highlights and Achievements

• 2021: Moved to a new building to accommodate a growing workforce.

• 2020: Ranked as Germany's fastest-growing mid-sized company by "Handelsblatt" and among the Top 50 most innovative mid-sized firms by "Wirtschaftswoche."

• 2019: Received similar accolades for innovation and growth.

• 2014: Developed an advanced pump for cooled heart catheter ablation procedures.

• 2012: Completed and launched the G4 RF Ablation system, replacing the EP-Shuttle.

• 2004: Introduced the Stimuplex HNS12 nerve stimulator for peripheric regional anesthesia.

5. Compliance and Quality Management

• Stockert is committed to delivering products that meet stringent regulatory standards across regional, national, and international markets. The company's adherence to ISO 13485 standards and participation in programs like the FDA Quality System Regulation and Medical Device Single Audit Program ensure high compliance and customer satisfaction.

6. Achievements and Recognition

• Listed among the Top 10 Neuromodulation Solution Providers in Europe for 2022 by MedTech Outlook.

• Continuous recognition for innovative approaches and design intuitive complex medical technology setups.

7. Career Opportunities

• Stockert fosters a work environment focused on mutual success and personal growth, seeking motivated individuals to join diverse skill sets, including technology & innovation, regulatory affairs, and IT systems management.

8. Sustainability and Corporate Responsibility

• As a medical device manufacturer, Stockert holds a strong commitment to societal responsibility, sustainability, and compliance, committed to enhancing patient safety and satisfaction.

This detailed company research report aims to encapsulate the essence of Stockert GmbH, focusing primarily on information available from the outlined company data.